Clinical trial
The Circulating Cell-free Genome Atlas Study
NCT02889978 · GRAIL, Inc., Industry · Unknown status
Key facts
| NCT number | NCT02889978 |
|---|---|
| Title | The Circulating Cell-free Genome Atlas Study |
| Official title | The Circulating Cell-free Genome Atlas Study |
| Acronym | CCGA |
| Lead sponsor | GRAIL, Inc., Industry |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Neoplasms, Cancer |
| Enrollment | 15,254 |
| Start date | Aug 4, 2016 |
| Primary completion | Mar 1, 2024 |
| Completion | Mar 1, 2024 |
| First posted | Sep 7, 2016 |
| Last update posted | Sep 13, 2023 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: